Biomarker underuse contributes to an inability to phenotype patients with severe uncontrolled asthma.
- DOI
- 10.2500/aap.2022.43.220038
- Published
- 2022 Sep 27
- Container
- Allergy and asthma proceedings
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2500/aap.2022.43.220038,
title = {Biomarker underuse contributes to an inability to phenotype patients with severe uncontrolled asthma.},
author = {Khan NS and Rubin E and McKenna B and Palowitch BL and Sonnenberg F and Argon J and Panettieri RA Jr},
year = {2022},
journal = {Allergy and asthma proceedings},
doi = {10.2500/aap.2022.43.220038},
url = {https://doi.org/10.2500/aap.2022.43.220038}
}RIS
TY - JOUR TI - Biomarker underuse contributes to an inability to phenotype patients with severe uncontrolled asthma. AU - Khan NS AU - Rubin E AU - McKenna B AU - Palowitch BL AU - Sonnenberg F AU - Argon J AU - Panettieri RA Jr PY - 2022 JO - Allergy and asthma proceedings DO - 10.2500/aap.2022.43.220038 UR - https://doi.org/10.2500/aap.2022.43.220038 ER -
APA
NS, K., E, R., B, M., BL, P., F, S., J, A., & Jr, P. R. (2022). Biomarker underuse contributes to an inability to phenotype patients with severe uncontrolled asthma.. Allergy and asthma proceedings. https://doi.org/10.2500/aap.2022.43.220038
Source records
- pubmed · retrieved 2026-09-25T02:54:58.858Z